JNJ vs CRL
By Alex · Tickerpine
Johnson & Johnson vs Charles River Laboratories International, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | CRL |
|---|---|---|
| Price | $273.14 | $297.64 |
| Market cap | $658.24B | $14.34B |
| P/E ratio | 31.7 | — |
| ROE | 25.74% | -7.52% |
| Profit margin | 21.48% | -5.96% |
| Revenue growth | 6.60% | -2.70% |
| Dividend yield | 1.96% | — |
| Beta | 0.23 | 1.38 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs CRL in plain English
- JNJ is the bigger company — about 45.9× the market cap of CRL.
- JNJ earns a higher return on equity (26% vs -8%).
- JNJ is growing revenue faster (7% vs -3%).
- JNJ pays a dividend (1.96%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
CRL return calculator
See what $1,000 in Charles River Laboratories International, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.